JP2016128501A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016128501A5 JP2016128501A5 JP2016026263A JP2016026263A JP2016128501A5 JP 2016128501 A5 JP2016128501 A5 JP 2016128501A5 JP 2016026263 A JP2016026263 A JP 2016026263A JP 2016026263 A JP2016026263 A JP 2016026263A JP 2016128501 A5 JP2016128501 A5 JP 2016128501A5
- Authority
- JP
- Japan
- Prior art keywords
- disorders
- crystalline form
- autoimmune
- mediated
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000010099 disease Diseases 0.000 claims 10
- 230000001363 autoimmune Effects 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- 230000001404 mediated Effects 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 238000000634 powder X-ray diffraction Methods 0.000 claims 3
- 208000008787 Cardiovascular Disease Diseases 0.000 claims 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N MeOtBu Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims 2
- 206010061284 Mental disease Diseases 0.000 claims 2
- 208000008466 Metabolic Disease Diseases 0.000 claims 2
- 206010053643 Neurodegenerative disease Diseases 0.000 claims 2
- 206010038428 Renal disease Diseases 0.000 claims 2
- 238000000113 differential scanning calorimetry Methods 0.000 claims 2
- 239000012458 free base Substances 0.000 claims 2
- 200000000018 inflammatory disease Diseases 0.000 claims 2
- 201000006370 kidney failure Diseases 0.000 claims 2
- 230000002062 proliferating Effects 0.000 claims 2
- 230000000241 respiratory Effects 0.000 claims 2
- 230000003612 virological Effects 0.000 claims 2
- 230000000875 corresponding Effects 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000003449 preventive Effects 0.000 claims 1
- 150000003839 salts Chemical group 0.000 claims 1
Claims (11)
- 化合物（Ｉ）
（Ｉ）
が、遊離塩基の形態、又はその溶媒和物であり、
７．５３±０．２、９．６０±０．２、１０．２２±０．２、１１．２９±０．２、１１．６６±０．２、１２．２６±０．２、１２．６２±０．２、１３．１７±０．２、１４．０６±０．２、１４．８５±０．２、１５．１５±０．２、１５．５７±０．２、１６．９９±０．２、１７．６８±０．２、１８．３０±０．２、１８．３９±０．２、１８．６３±０．２、１８．９７±０．２、１９．３２±０．２及び２０．２０±０．２から選択される２［シータ］値における２又は３以上の回折ピークを有するｘ線粉末回折パターンを特徴とする、前記化合物の結晶性形態［形態Ａ］。 - ｘ線粉末回折パターンが、７．５３±０．２、１２．２６±０．２、１４．０６±０．２、１４．８５±０．２及び１５．５７±０．２から選択される２［シータ］値における２又は３以上の回折ピークを含む、請求項１に記載の結晶性形態。
- ピーク位置が図５に示されている又は表１に記載されているパターンのピーク位置と実質的に一致するｘ線粉末回折パターンを特徴とする、請求項１に記載の結晶性形態。
- 約１３０℃〜約１４０℃の温度で最大吸熱ピークを示す、毎分２０℃の加熱速度で記録された示差走査熱量測定トレースを特徴とする、請求項１に記載の結晶性形態。
- 図６に示されているものと実質的に一致する示差走査熱量測定トレースを特徴とする、請求項１に記載の結晶性形態。
- ａ＝１５．１９±２Å、ｂ＝１８．３４±２Å、ｃ＝８．６５±２Å及び［ベータ］＝９５．５３±２°の単位格子寸法を持つ単斜晶Ｐ２１／ｃ空間群である、請求項１に記載の結晶性形態。
- 請求項１〜６のいずれかに記載の結晶性形態と、薬学的に許容される担体、希釈剤又は賦形剤とを含む、医薬組成物。
- 医療において使用するための、請求項１〜６のいずれかに記載の結晶性形態。
- 増殖性障害、免疫介在性及び炎症性障害、自己免疫性及び自己免疫介在性障害、腎臓障害、心血管障害、眼科障害、神経変性障害、精神障害、ウイルス性障害、代謝障害並びに／又は呼吸器障害の予防又は治療剤であって、請求項１〜６のいずれかに記載の結晶性形態を含む前記予防又は治療剤。
- 増殖性障害、免疫介在性及び炎症性障害、自己免疫性及び自己免疫介在性障害、腎臓障害、心血管障害、眼科障害、神経変性障害、精神障害、ウイルス性障害、代謝障害並びに／又は呼吸器障害の予防又は治療用薬剤の調製における、請求項１〜６のいずれかに記載の結晶性形態の使用。
- 遊離塩基形態Ａの化合物（Ｉ）をメチルｔ−ブチルエーテル（ＭＴＢＥ）から結晶化させるステップを含む、請求項１に記載の化合物（Ｉ）の結晶性遊離塩基（形態Ａ）を調製する方法。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1001075.9 | 2010-01-22 | ||
| GBGB1001075.9A GB201001075D0 (en) | 2010-01-22 | 2010-01-22 | Crystalline forms |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012549413A Division JP5951506B2 (ja) | 2010-01-22 | 2011-01-24 | プリン誘導体の結晶性形態 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016128501A JP2016128501A (ja) | 2016-07-14 |
| JP2016128501A5 true JP2016128501A5 (ja) | 2016-11-10 |
| JP6114849B2 JP6114849B2 (ja) | 2017-04-12 |
Family
ID=42045946
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012549413A Active JP5951506B2 (ja) | 2010-01-22 | 2011-01-24 | プリン誘導体の結晶性形態 |
| JP2016026263A Active JP6114849B2 (ja) | 2010-01-22 | 2016-02-15 | プリン誘導体の結晶性形態 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012549413A Active JP5951506B2 (ja) | 2010-01-22 | 2011-01-24 | プリン誘導体の結晶性形態 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8889861B2 (ja) |
| EP (2) | EP3150602B1 (ja) |
| JP (2) | JP5951506B2 (ja) |
| KR (2) | KR101927083B1 (ja) |
| CN (2) | CN102985423B (ja) |
| ES (2) | ES2694289T3 (ja) |
| GB (1) | GB201001075D0 (ja) |
| PL (2) | PL2526101T3 (ja) |
| SG (2) | SG182439A1 (ja) |
| TR (1) | TR201816159T4 (ja) |
| WO (1) | WO2011089401A1 (ja) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006097931A2 (en) | 2005-03-17 | 2006-09-21 | Valtech Cardio, Ltd. | Mitral valve treatment techniques |
| US11259924B2 (en) | 2006-12-05 | 2022-03-01 | Valtech Cardio Ltd. | Implantation of repair devices in the heart |
| US9883943B2 (en) | 2006-12-05 | 2018-02-06 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
| US11660190B2 (en) | 2007-03-13 | 2023-05-30 | Edwards Lifesciences Corporation | Tissue anchors, systems and methods, and devices |
| US8382829B1 (en) | 2008-03-10 | 2013-02-26 | Mitralign, Inc. | Method to reduce mitral regurgitation by cinching the commissure of the mitral valve |
| CA2728078A1 (en) | 2008-06-16 | 2010-01-14 | Valtech Cardio, Ltd. | Annuloplasty devices and methods of delivery therefor |
| US8545553B2 (en) | 2009-05-04 | 2013-10-01 | Valtech Cardio, Ltd. | Over-wire rotation tool |
| US10517719B2 (en) | 2008-12-22 | 2019-12-31 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
| US8241351B2 (en) | 2008-12-22 | 2012-08-14 | Valtech Cardio, Ltd. | Adjustable partial annuloplasty ring and mechanism therefor |
| US8715342B2 (en) | 2009-05-07 | 2014-05-06 | Valtech Cardio, Ltd. | Annuloplasty ring with intra-ring anchoring |
| EP2379008B1 (en) | 2008-12-22 | 2021-02-17 | Valtech Cardio, Ltd. | Adjustable annuloplasty devices |
| US8353956B2 (en) | 2009-02-17 | 2013-01-15 | Valtech Cardio, Ltd. | Actively-engageable movement-restriction mechanism for use with an annuloplasty structure |
| US9968452B2 (en) | 2009-05-04 | 2018-05-15 | Valtech Cardio, Ltd. | Annuloplasty ring delivery cathethers |
| US10098737B2 (en) | 2009-10-29 | 2018-10-16 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
| US9180007B2 (en) | 2009-10-29 | 2015-11-10 | Valtech Cardio, Ltd. | Apparatus and method for guide-wire based advancement of an adjustable implant |
| EP2506777B1 (en) | 2009-12-02 | 2020-11-25 | Valtech Cardio, Ltd. | Combination of spool assembly coupled to a helical anchor and delivery tool for implantation thereof |
| US8870950B2 (en) | 2009-12-08 | 2014-10-28 | Mitral Tech Ltd. | Rotation-based anchoring of an implant |
| GB201001075D0 (en) | 2010-01-22 | 2010-03-10 | Cyclacel Ltd | Crystalline forms |
| US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
| US10792152B2 (en) | 2011-06-23 | 2020-10-06 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
| US8858623B2 (en) | 2011-11-04 | 2014-10-14 | Valtech Cardio, Ltd. | Implant having multiple rotational assemblies |
| EP3970627B1 (en) | 2011-11-08 | 2023-12-20 | Edwards Lifesciences Innovation (Israel) Ltd. | Controlled steering functionality for implant-delivery tool |
| US10143553B2 (en) | 2011-12-12 | 2018-12-04 | Cardiac Implants, Llc | Heart valve repair device |
| CA2885354A1 (en) | 2012-09-29 | 2014-04-03 | Mitralign, Inc. | Plication lock delivery system and method of use thereof |
| EP3517052A1 (en) | 2012-10-23 | 2019-07-31 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
| WO2014064695A2 (en) | 2012-10-23 | 2014-05-01 | Valtech Cardio, Ltd. | Percutaneous tissue anchor techniques |
| WO2014087402A1 (en) | 2012-12-06 | 2014-06-12 | Valtech Cardio, Ltd. | Techniques for guide-wire based advancement of a tool |
| WO2014115149A2 (en) | 2013-01-24 | 2014-07-31 | Mitraltech Ltd. | Ventricularly-anchored prosthetic valves |
| EP2961351B1 (en) | 2013-02-26 | 2018-11-28 | Mitralign, Inc. | Devices for percutaneous tricuspid valve repair |
| US10449333B2 (en) | 2013-03-14 | 2019-10-22 | Valtech Cardio, Ltd. | Guidewire feeder |
| US9724195B2 (en) | 2013-03-15 | 2017-08-08 | Mitralign, Inc. | Translation catheters and systems |
| WO2014189830A1 (en) * | 2013-05-20 | 2014-11-27 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Calcium channel agonists |
| US10070857B2 (en) | 2013-08-31 | 2018-09-11 | Mitralign, Inc. | Devices and methods for locating and implanting tissue anchors at mitral valve commissure |
| WO2015059699A2 (en) | 2013-10-23 | 2015-04-30 | Valtech Cardio, Ltd. | Anchor magazine |
| US9610162B2 (en) | 2013-12-26 | 2017-04-04 | Valtech Cardio, Ltd. | Implantation of flexible implant |
| US10195030B2 (en) | 2014-10-14 | 2019-02-05 | Valtech Cardio, Ltd. | Leaflet-restraining techniques |
| WO2016125160A1 (en) | 2015-02-05 | 2016-08-11 | Mitraltech Ltd. | Prosthetic valve with axially-sliding frames |
| US20160256269A1 (en) | 2015-03-05 | 2016-09-08 | Mitralign, Inc. | Devices for treating paravalvular leakage and methods use thereof |
| SG10202010021SA (en) | 2015-04-30 | 2020-11-27 | Valtech Cardio Ltd | Annuloplasty technologies |
| US10751182B2 (en) | 2015-12-30 | 2020-08-25 | Edwards Lifesciences Corporation | System and method for reshaping right heart |
| WO2017117370A2 (en) | 2015-12-30 | 2017-07-06 | Mitralign, Inc. | System and method for reducing tricuspid regurgitation |
| US10531866B2 (en) | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
| US10702274B2 (en) | 2016-05-26 | 2020-07-07 | Edwards Lifesciences Corporation | Method and system for closing left atrial appendage |
| GB201611910D0 (en) | 2016-07-08 | 2016-08-24 | Valtech Cardio Ltd | Adjustable annuloplasty device with alternating peaks and troughs |
| CN114587712A (zh) | 2016-08-10 | 2022-06-07 | 卡迪尔维尔福股份有限公司 | 具有同轴框架的人工瓣膜 |
| KR102524773B1 (ko) * | 2017-01-26 | 2023-04-21 | 싸이클라셀 리미티드 | 퓨린 유도체의 제조 방법 |
| US11045627B2 (en) | 2017-04-18 | 2021-06-29 | Edwards Lifesciences Corporation | Catheter system with linear actuation control mechanism |
| US10835221B2 (en) | 2017-11-02 | 2020-11-17 | Valtech Cardio, Ltd. | Implant-cinching devices and systems |
| US11135062B2 (en) | 2017-11-20 | 2021-10-05 | Valtech Cardio Ltd. | Cinching of dilated heart muscle |
| CA3086884A1 (en) | 2018-01-24 | 2019-08-01 | Valtech Cardio, Ltd. | Contraction of an annuloplasty structure |
| EP3743014B1 (en) | 2018-01-26 | 2023-07-19 | Edwards Lifesciences Innovation (Israel) Ltd. | Techniques for facilitating heart valve tethering and chord replacement |
| CA3106104A1 (en) | 2018-07-12 | 2020-01-16 | Valtech Cardio, Ltd. | Annuloplasty systems and locking tools therefor |
| AU2020375903A1 (en) | 2019-10-29 | 2021-12-23 | Edwards Lifesciences Innovation (Israel) Ltd. | Annuloplasty and tissue anchor technologies |
| GB202000901D0 (en) | 2020-01-22 | 2020-03-04 | Cyclacel Ltd | Process |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA72748C2 (en) | 1998-11-10 | 2005-04-15 | Astrazeneca Ab | A novel crystalline form of omeprazole |
| DE60205376T2 (de) | 2001-06-27 | 2006-04-06 | Cyclacel Ltd. | 2,6,9-substituierte purinderivate und ihre verwendung bei der behandlung proliferativer krankheiten |
| GB0219054D0 (en) | 2002-08-15 | 2002-09-25 | Cyclacel Ltd | New purine derivatives |
| GB0219052D0 (en) | 2002-08-15 | 2002-09-25 | Cyclacel Ltd | New puring derivatives |
| GB0706633D0 (en) * | 2007-04-04 | 2007-05-16 | Cyclacel Ltd | Combination |
| GB0706632D0 (en) | 2007-04-04 | 2007-05-16 | Cyclacel Ltd | New purine derivatives |
| GB201001075D0 (en) | 2010-01-22 | 2010-03-10 | Cyclacel Ltd | Crystalline forms |
-
2010
- 2010-01-22 GB GBGB1001075.9A patent/GB201001075D0/en not_active Ceased
-
2011
- 2011-01-24 JP JP2012549413A patent/JP5951506B2/ja active Active
- 2011-01-24 KR KR1020187014008A patent/KR101927083B1/ko active IP Right Grant
- 2011-01-24 ES ES16186685.0T patent/ES2694289T3/es active Active
- 2011-01-24 US US13/574,488 patent/US8889861B2/en active Active
- 2011-01-24 SG SG2012050696A patent/SG182439A1/en unknown
- 2011-01-24 CN CN201180015141.5A patent/CN102985423B/zh active Active
- 2011-01-24 CN CN201710626907.2A patent/CN107400134B/zh active Active
- 2011-01-24 EP EP16186685.0A patent/EP3150602B1/en active Active
- 2011-01-24 EP EP11701855.6A patent/EP2526101B1/en active Active
- 2011-01-24 SG SG10201500451TA patent/SG10201500451TA/en unknown
- 2011-01-24 KR KR1020127021718A patent/KR101860806B1/ko active IP Right Grant
- 2011-01-24 PL PL11701855T patent/PL2526101T3/pl unknown
- 2011-01-24 ES ES11701855.6T patent/ES2613716T3/es active Active
- 2011-01-24 TR TR2018/16159T patent/TR201816159T4/tr unknown
- 2011-01-24 PL PL16186685T patent/PL3150602T3/pl unknown
- 2011-01-24 WO PCT/GB2011/000087 patent/WO2011089401A1/en active Application Filing
-
2014
- 2014-10-27 US US14/524,686 patent/US9573951B2/en active Active
-
2016
- 2016-02-15 JP JP2016026263A patent/JP6114849B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016128501A5 (ja) | ||
| JP2018115191A5 (ja) | ||
| JP2013518041A5 (ja) | ||
| JP2016528179A5 (ja) | ||
| HRP20210388T1 (hr) | Kristalni polimorf slobodne baze od 2-hidroksi-6-((2-(1-izopropil-1h-pirazol-5-il)piridin-3-il)metoksi)benzaldehida | |
| JP2018520205A5 (ja) | ||
| JP2019528276A5 (ja) | ||
| JP2015038149A5 (ja) | ||
| JP2020511467A5 (ja) | ||
| JP2014507455A5 (ja) | ||
| JP2010500293A5 (ja) | ||
| JP2015529657A5 (ja) | ||
| FI2744810T4 (fi) | Tenofoviirialafenamidihemifumaraatti | |
| JP2013543867A5 (ja) | ||
| JP2015522037A5 (ja) | ||
| JP2016539985A5 (ja) | ||
| JP2018521121A5 (ja) | ||
| RU2017142958A (ru) | Кристаллы азабициклического соединения | |
| JP2020536893A5 (ja) | ||
| CN107847521A (zh) | 药物共晶组合物及其用途 | |
| JP2015516425A5 (ja) | ||
| RU2015134420A (ru) | Кристаллические формы { [1-циано-5-(4-хлорофеноксид)-4-гидроксид-изохинолин-3-карбонил]-амино} -уксусной кислоты | |
| JP2018520147A5 (ja) | ||
| JP2016529315A5 (ja) | ||
| JP2021530565A5 (ja) |